Asensus Surgical, Inc. (ASXC)
NYSEAMERICAN: ASXC · IEX Real-Time Price · USD
0.340
+0.004 (1.04%)
At close: Jul 19, 2024, 4:00 PM
0.338
-0.002 (-0.44%)
Pre-market: Jul 22, 2024, 7:08 AM EDT
Asensus Surgical Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Asensus Surgical stock has a target of 0.35, which predicts an increase of 3.09% from the current stock price of 0.34.
Analyst Consensus: Hold
* Price targets were last updated on May 16, 2024.
Analyst Ratings
The average analyst rating for ASXC stock from 2 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $0.35 | Hold | Reiterates | $0.35 | +3.09% | May 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $2 → $0.35 | Strong Buy → Hold | Downgrades | $2 → $0.35 | +3.09% | Apr 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $2 | Strong Buy | Maintains | $2 | +489.10% | Mar 22, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 16, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $2 | Strong Buy | Reiterates | $2 | +489.10% | Nov 15, 2023 |
Financial Forecast
Revenue This Year
12.30M
from 8.58M
Increased by 43.43%
Revenue Next Year
22.35M
from 12.30M
Increased by 81.68%
EPS This Year
-0.24
from -0.31
EPS Next Year
-0.19
from -0.24
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 15.0M | 33.1M | 54.0M | 111.8M | 163.1M |
| Avg | 12.3M | 22.4M | 52.4M | 108.6M | 158.4M |
| Low | 9.6M | 12.1M | 50.4M | 104.3M | 152.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 75.3% | 169.1% | 141.4% | 113.3% | 50.1% |
| Avg | 43.4% | 81.7% | 134.5% | 107.2% | 45.9% |
| Low | 12.0% | -2.0% | 125.3% | 99.1% | 40.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.22 | -0.14 | -0.08 | 0.03 | 0.13 |
| Avg | -0.24 | -0.19 | -0.08 | 0.03 | 0.12 |
| Low | -0.26 | -0.25 | -0.08 | 0.03 | 0.12 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 311.8% |
| Avg | - | - | - | - | 300.0% |
| Low | - | - | - | - | 284.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.